CALLA: Efficacy and safety of durvalumab with and following concurrent chemoradiotherapy (CCRT) versus CCRT alone in women with locally advanced cervical cancer: A phase III, randomized, double-blind, multicenter study.

Bradley J. Monk,Jyoti Mayadev,Ana T Nunes,Alicja Dabrowska Brown,Michelle Marcovitz,M Lanasa

CALLA: Efficacy and safety of durvalumab with and following concurrent chemoradiotherapy (CCRT) versus CCRT alone in women with locally advanced cervical cancer: A phase III, randomized, double-blind, multicenter study.

2019

Bradley J. Monk
Jyoti Mayadev
Ana T Nunes
Alicja Dabrowska Brown
Michelle Marcovitz
M Lanasa

TPS5597Background: CCRT is the standard of care for locally advanced cervical cancer. CCRT with PD-1/PD-L1 pathway blockade may promote a more immunogenic environment through increased phagocytosis...

Keywords:

Chemoradiotherapy
Durvalumab
Physical therapy
Calla
Oncology
Cervical cancer
Internal medicine
Medicine
locally advanced
multicenter study
double blind
concurrent chemoradiotherapy
Blockade

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations